As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...